OCS

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Oculis Holding AG Ordinary shares

NASDAQ | OCS

21.55

USD

+$0.00

(

+0.00%

)

At Close (As of Oct 16, 2025)

$1.12B

Market Cap

-

P/E Ratio

-2.88

EPS

$23.08

52 Week High

$14.00

52 Week Low

HEALTHCARE

Sector

OCS Chart

Recent Chart
Price Action

OCS Technicals

Tags:

OCS Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (CHF)
Gross Profit -$51M
Total Revenue $686K
Cost Of Revenue $52M
Costof Goods And Services Sold $52M
Operating Income -$73M
Selling General And Administrative $22M
Research And Development $52M
Operating Expenses $22M
Investment Income Net -
Net Interest Income $1.5M
Interest Income $2.2M
Interest Expense $639K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $406K
Income Before Tax -$86M
Income Tax Expense -$160K
Interest And Debt Expense -
Net Income From Continuing Operations -$86M
Comprehensive Income Net Of Tax -
Ebit -$73M
Ebitda -$73M
Net Income -$86M

Revenue & Profitability

Earnings Performance

OCS Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (CHF)
Total Assets $120M
Total Current Assets $105M
Cash And Cash Equivalents At Carrying Value $28M
Cash And Short Term Investments $28M
Inventory -
Current Net Receivables $777K
Total Non Current Assets $15M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $13M
Intangible Assets Excluding Goodwill $13M
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $71M
Other Current Assets $5.5M
Other Non Current Assets -
Total Liabilities $47M
Total Current Liabilities $44M
Current Accounts Payable $5.9M
Deferred Revenue -
Current Debt -
Short Term Debt $315K
Total Non Current Liabilities $2.7M
Capital Lease Obligations $1.2M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $1.2M
Other Current Liabilities $38M
Other Non Current Liabilities -
Total Shareholder Equity $73M
Treasury Stock -
Retained Earnings -$286M
Common Stock $446K
Common Stock Shares Outstanding $40M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (CHF)
Operating Cashflow -$47M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $406K
Capital Expenditures $230K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$18M
Cashflow From Financing $54M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$86M

yearly Income Statement (As of Dec 31, 2024)

Field Value (CHF)
Gross Profit -$51M
Total Revenue $686K
Cost Of Revenue $52M
Costof Goods And Services Sold $52M
Operating Income -$73M
Selling General And Administrative $22M
Research And Development $52M
Operating Expenses $22M
Investment Income Net -
Net Interest Income $1.5M
Interest Income $2.2M
Interest Expense $639K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $406K
Income Before Tax -$86M
Income Tax Expense -$160K
Interest And Debt Expense -
Net Income From Continuing Operations -$86M
Comprehensive Income Net Of Tax -
Ebit -$73M
Ebitda -$73M
Net Income -$86M

OCS News

OCS Profile

Oculis Holding AG Ordinary shares Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Oculis Holding AG is an innovative biopharmaceutical company based in Zug, Switzerland, specializing in the development of groundbreaking topical therapies for a range of ophthalmic diseases affecting both the front and back of the eye. Leveraging advanced formulation technologies, Oculis aims to address significant unmet medical needs in vision care, focusing on enhancing patient outcomes through effective and user-friendly treatment options. With its robust pipeline, the company is positioned to make a meaningful impact in the ophthalmology space, catering to both acute and chronic eye conditions.

VHAI
-20.00%
$0.00
VIVK
-1.72%
$0.28
YYAI
-10.71%
$0.12
BURU
+1.07%
$0.34
IVF
+85.67%
$1.40
EPWK
+26.46%
$0.09
NVDA
-0.11%
$179.83
BITF
-18.39%
$5.28
RXRX
-7.21%
$6.29
CGBS
-39.47%
$0.03
COOT
+173.57%
$2.64
PLUG
-8.70%
$3.51
ADAP
+6.57%
$0.19
BYND
-22.39%
$0.52
YDKG
-54.14%
$0.08
NVTS
+3.10%
$15.63
RGTI
-14.85%
$47.97
DNN
-2.83%
$3.08
LAES
-2.09%
$7.49
NIO
-1.09%
$6.74
MIRA
+36.36%
$1.80
SCNX
-17.63%
$0.58
F
-0.27%
$11.72
BBD
+1.71%
$3.25
WHWK
+24.28%
$2.61
KVUE
-13.34%
$14.09
ACHR
-8.90%
$11.87
INTC
-0.83%
$36.84
TLRY
-8.33%
$1.54
HPE
-10.06%
$22.52
TSLA
-1.47%
$428.75
ONDS
-13.77%
$8.19
IONZ
+18.46%
$3.41
DFLI
-32.48%
$1.33
AXDX
-61.36%
$0.03
ETHD
+6.47%
$3.78
RIG
-2.56%
$3.22
CAN
-14.28%
$1.68
AAL
-4.88%
$11.89
AMD
-1.33%
$235.40
SOFI
-6.13%
$26.31
GDXD
-7.91%
$0.61
MARA
-11.62%
$20.18
BTBT
-9.11%
$3.69
GNPX
-43.39%
$0.47
QBTS
-9.62%
$40.47
BTG
+3.96%
$5.89
FEMY
+33.89%
$0.73
VSEE
-13.85%
$0.51
QS
-13.41%
$15.45
RR
-7.95%
$5.67
GPUS
-6.14%
$0.36
LGCB
+19.39%
$1.97
ABAT
-21.00%
$8.94
NAK
-4.34%
$2.64
SNAP
-1.83%
$7.76
CIFR
-10.98%
$18.72
CRML
-14.52%
$19.42
QSI
-3.23%
$2.54
RF
-5.98%
$23.26
RGTZ
+30.51%
$11.35
PFE
-0.65%
$24.23
MASK
+17.35%
$0.57
UUUU
-12.80%
$21.79
QUBT
-12.12%
$18.65
KEY
-5.35%
$16.78
HBAN
-5.00%
$15.39
IREN
-8.94%
$61.89
PLTR
-0.83%
$178.12
SOUN
-2.99%
$20.76
WTO
-88.87%
$0.13
CLSK
-13.92%
$19.97
SMR
-10.87%
$47.62
T
+0.46%
$26.19
RMBL
+60.50%
$3.21
GRAB
-3.54%
$5.71
AAPL
-0.75%
$247.45
ASST
-11.57%
$0.84
ADD
-25.47%
$0.05
WOK
+3.29%
$0.05
SOND
+79.34%
$1.65
AUUD
+0.97%
$2.06
NOK
+0.53%
$5.68
WULF
-9.53%
$13.99
BAC
-4.03%
$50.17
MU
+4.60%
$200.77
JOBY
-8.66%
$16.07
IONQ
-9.33%
$65.65
APLD
-1.69%
$37.11
NEHC
+9.12%
$3.35
CLF
-0.07%
$13.95
SRM
+53.27%
$10.30
SATL
-29.71%
$2.91
BMNR
-4.90%
$51.16
TOVX
-47.86%
$0.43
KDLY
+1.29%
$0.79
SLNH
-1.39%
$4.23
JBLU
-4.94%
$4.70
AMC
-2.12%
$2.76
AMZN
-0.81%
$213.82
VHAI
-20.00%
$0.00
VIVK
-1.72%
$0.28
YYAI
-10.71%
$0.12
BURU
+1.07%
$0.34
IVF
+85.67%
$1.40
EPWK
+26.46%
$0.09
NVDA
-0.11%
$179.83
BITF
-18.39%
$5.28
RXRX
-7.21%
$6.29
CGBS
-39.47%
$0.03
COOT
+173.57%
$2.64
PLUG
-8.70%
$3.51
ADAP
+6.57%
$0.19
BYND
-22.39%
$0.52
YDKG
-54.14%
$0.08
NVTS
+3.10%
$15.63
RGTI
-14.85%
$47.97
DNN
-2.83%
$3.08
LAES
-2.09%
$7.49
NIO
-1.09%
$6.74
MIRA
+36.36%
$1.80
SCNX
-17.63%
$0.58
F
-0.27%
$11.72
BBD
+1.71%
$3.25
WHWK
+24.28%
$2.61
KVUE
-13.34%
$14.09
ACHR
-8.90%
$11.87
INTC
-0.83%
$36.84
TLRY
-8.33%
$1.54
HPE
-10.06%
$22.52
TSLA
-1.47%
$428.75
ONDS
-13.77%
$8.19
IONZ
+18.46%
$3.41
DFLI
-32.48%
$1.33
AXDX
-61.36%
$0.03
ETHD
+6.47%
$3.78
RIG
-2.56%
$3.22
CAN
-14.28%
$1.68
AAL
-4.88%
$11.89
AMD
-1.33%
$235.40
SOFI
-6.13%
$26.31
GDXD
-7.91%
$0.61
MARA
-11.62%
$20.18
BTBT
-9.11%
$3.69
GNPX
-43.39%
$0.47
QBTS
-9.62%
$40.47
BTG
+3.96%
$5.89
FEMY
+33.89%
$0.73
VSEE
-13.85%
$0.51
QS
-13.41%
$15.45
RR
-7.95%
$5.67
GPUS
-6.14%
$0.36
LGCB
+19.39%
$1.97
ABAT
-21.00%
$8.94
NAK
-4.34%
$2.64
SNAP
-1.83%
$7.76
CIFR
-10.98%
$18.72
CRML
-14.52%
$19.42
QSI
-3.23%
$2.54
RF
-5.98%
$23.26
RGTZ
+30.51%
$11.35
PFE
-0.65%
$24.23
MASK
+17.35%
$0.57
UUUU
-12.80%
$21.79
QUBT
-12.12%
$18.65
KEY
-5.35%
$16.78
HBAN
-5.00%
$15.39
IREN
-8.94%
$61.89
PLTR
-0.83%
$178.12
SOUN
-2.99%
$20.76
WTO
-88.87%
$0.13
CLSK
-13.92%
$19.97
SMR
-10.87%
$47.62
T
+0.46%
$26.19
RMBL
+60.50%
$3.21
GRAB
-3.54%
$5.71
AAPL
-0.75%
$247.45
ASST
-11.57%
$0.84
ADD
-25.47%
$0.05
WOK
+3.29%
$0.05
SOND
+79.34%
$1.65
AUUD
+0.97%
$2.06
NOK
+0.53%
$5.68
WULF
-9.53%
$13.99
BAC
-4.03%
$50.17
MU
+4.60%
$200.77
JOBY
-8.66%
$16.07
IONQ
-9.33%
$65.65
APLD
-1.69%
$37.11
NEHC
+9.12%
$3.35
CLF
-0.07%
$13.95
SRM
+53.27%
$10.30
SATL
-29.71%
$2.91
BMNR
-4.90%
$51.16
TOVX
-47.86%
$0.43
KDLY
+1.29%
$0.79
SLNH
-1.39%
$4.23
JBLU
-4.94%
$4.70
AMC
-2.12%
$2.76
AMZN
-0.81%
$213.82
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.